Correlation Between Coherus BioSciences and Neoleukin Therapeutics
Can any of the company-specific risk be diversified away by investing in both Coherus BioSciences and Neoleukin Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coherus BioSciences and Neoleukin Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Coherus BioSciences and Neoleukin Therapeutics, you can compare the effects of market volatilities on Coherus BioSciences and Neoleukin Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coherus BioSciences with a short position of Neoleukin Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coherus BioSciences and Neoleukin Therapeutics.
Diversification Opportunities for Coherus BioSciences and Neoleukin Therapeutics
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Coherus and Neoleukin is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Coherus BioSciences and Neoleukin Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neoleukin Therapeutics and Coherus BioSciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Coherus BioSciences are associated (or correlated) with Neoleukin Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neoleukin Therapeutics has no effect on the direction of Coherus BioSciences i.e., Coherus BioSciences and Neoleukin Therapeutics go up and down completely randomly.
Pair Corralation between Coherus BioSciences and Neoleukin Therapeutics
Given the investment horizon of 90 days Coherus BioSciences is expected to generate 1.69 times more return on investment than Neoleukin Therapeutics. However, Coherus BioSciences is 1.69 times more volatile than Neoleukin Therapeutics. It trades about -0.04 of its potential returns per unit of risk. Neoleukin Therapeutics is currently generating about -0.1 per unit of risk. If you would invest 814.00 in Coherus BioSciences on August 29, 2024 and sell it today you would lose (686.00) from holding Coherus BioSciences or give up 84.28% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 13.74% |
| Values | Daily Returns |
Coherus BioSciences vs. Neoleukin Therapeutics
Performance |
| Timeline |
| Coherus BioSciences |
| Neoleukin Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Coherus BioSciences and Neoleukin Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Coherus BioSciences and Neoleukin Therapeutics
The main advantage of trading using opposite Coherus BioSciences and Neoleukin Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coherus BioSciences position performs unexpectedly, Neoleukin Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neoleukin Therapeutics will offset losses from the drop in Neoleukin Therapeutics' long position.| Coherus BioSciences vs. Assembly Biosciences | Coherus BioSciences vs. Spero Therapeutics | Coherus BioSciences vs. Achilles Therapeutics PLC | Coherus BioSciences vs. Instil Bio |
| Neoleukin Therapeutics vs. CytomX Therapeutics | Neoleukin Therapeutics vs. Spero Therapeutics | Neoleukin Therapeutics vs. Instil Bio | Neoleukin Therapeutics vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |